Conference
Effectiveness of first-line therapy in patients with advanced non-clear renal cell carcinoma (nccRCC).
Abstract
304
Background: Current treatment principles for advanced nccRCC have been largely extrapolated from guidelines for clear cell RCC. Given the emerging randomized data for select nccRCC subtypes, real-world outcomes for these patients are informative particularly in the contemporary checkpoint inhibitor era. Methods: We performed an analysis using the Canadian Kidney Cancer information system (CKCis), a prospective database …
Authors
Laramee S; Ghosh S; Kollmannsberger CK; Hansen AR; Wood L; Soulieres D; Canil CM; Saleh R; Castonguay V; Bjarnason GA
Volume
40
Pagination
pp. 304-304
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 20, 2022
DOI
10.1200/jco.2022.40.6_suppl.304
Conference proceedings
Journal of Clinical Oncology
Issue
6_suppl
ISSN
0732-183X